Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (BIO) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BIO●NYSE
HealthcareMedical - Devices
$304.36
$3.38(1.12%)
U.S. Market opens in 6h 20m

Bio-Rad Laboratories, Inc. (BIO)

Meyka AI Score

Z

Key Financials

Market Cap8.2B
P/E Ratio49.61
EPS (TTM)$9.27
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$335.18
3 Months$357.76
1 Year Target$171.98

BIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $171.98.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 49.61 and a market capitalization of 8.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.07%
5-Day Change
1.40%
1-Month Change
6.86%
3-Month Change
1.73%
6-Month Change
-2.98%
Year-to-Date (YTD) Change
0.40%
1-Year Change
21.85%
3-Year Change
-21.54%
5-Year Change
-54.86%
All-Time (Max) Change
11846.41%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

74,500 Employees
IPO DateFeb 27, 1980
CountryUS
Actively Trading

Frequently Asked Questions